ARYx Therapeutics

ARYx Therapeutics

closed
Pharmaceutical company focused on retrometabolic drug designing and improving the safety of oral therapies for chronic diseases.

Launch date
Employees
Market cap
$238k
Enterprise valuation
$238k (Public information from Sep 2024)
Fremont California (HQ)
Authorizing premium user...